Key findings from clinical trials include: Slight increases in heart rate were noted, with mean increases of approximately 2-3 beats per minute compared to placebo Small reductions in systolic blood pressure (the upper number) were observed in some studies, typically in the range of 1-3 mmHg [1] [2] These blood pressure changes were generally not considered clinically significant for most patients The effects appeared to be more pronounced at higher doses, though individual responses may vary It is important to note that according to the MHRA-approved Summary of Product Characteristics (SmPC), hypertension (high blood pressure) is not listed as a common adverse effect of semaglutide
Together, these findings suggest that CBS refuels cysteine pools for GSH synthesis through de novo cysteine biosynthesis under cystine restricted conditions
Consider a semaglutide diet plan or tirzepatide diet plan that prioritizes protein at every meal
Our professionals are ready to guide you in achieving enhanced vitality and well-being through our B12 injection services
In type 2 diabetes, elevated plasma homocysteine is strongly linked to increased risk of cardiovascular disease and death
Controlled drugs and drug dependence Medicines guidance